Callan Family Office’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Buy
40,908
+163
+0.4% +$1.82K 0.01% 920
2026
Q1
$441K Buy
40,745
+1,684
+4% +$14.4K 0.01% 811
2025
Q4
$239K Buy
+39,061
New +$233K 0.01% 998
2025
Q3
– Sell
-35,390
Closed -$210K – 927
2025
Q2
$210K Buy
+35,390
New +$213K 0.01% 881

Other funds holding PTEN

Callan Family Office's PTEN Position: Q2 2026 in Review

Callan Family Office increased its Patterson-UTI (PTEN) stake by 0.4% in Q2 2026, buying an estimated $1.82K and bringing the position to 40,908 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #920.

Callan Family Office first reported a position in PTEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $441K in Q1 2026. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Callan Family Office held 40,908 shares of Patterson-UTI worth $376K as of Q2 2026.
  • Callan Family Office bought 163 Patterson-UTI shares in Q2 2026, an estimated $1.82K.
  • Patterson-UTI made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #920 holding.
  • Callan Family Office first reported a position in Patterson-UTI in Q2 2025 and has held it in 4 quarters since.
  • Callan Family Office's Patterson-UTI position peaked at $441K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.